GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (STU:NYZ) » Definitions » Institutional Ownership

Novacyt (STU:NYZ) Institutional Ownership : 0.06% (As of Jun. 16, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Novacyt Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Novacyt's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Novacyt's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Novacyt's Float Percentage Of Total Shares Outstanding is 0.00%.


Novacyt Institutional Ownership Historical Data

The historical data trend for Novacyt's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Institutional Ownership Chart

Novacyt Historical Data

The historical data trend for Novacyt can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.76 0.38 0.13 0.09 0.09 0.07 0.07 0.07 0.07 0.06

Novacyt Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Novacyt (STU:NYZ) Business Description

Traded in Other Exchanges
Address
13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (STU:NYZ) Headlines

No Headlines